• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子谱和 CD8+T 细胞在急性和慢性乙型肝炎中的发生。

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.

机构信息

Division of Hepatology, Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

出版信息

Front Immunol. 2022 Oct 24;13:1036612. doi: 10.3389/fimmu.2022.1036612. eCollection 2022.

DOI:10.3389/fimmu.2022.1036612
PMID:36353632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9637985/
Abstract

OBJECTIVE

We explore the expression of functional molecules on CD8+ T lymphocytes, cytokines concentration, and their correlation to occurrence of hepatitis B and hepatitis B virus (HBV) desoxyribose nucleic acid (DNA), hepatitis B surface antigen (HBsAg), hepatitis B envelope antigen (HBeAg), and alanine aminotransferase (ALT) in patients infected with HBV.

METHODS

This is a single center study. 32 patients with acute hepatitis B (AHB), 30 patients with immune tolerant (IT) phase chronic HBV infected, and 50 patients with chronic hepatitis B (CHB) were enrolled. The activation molecules (CD69) and the apoptosis-inducing molecules (CD178) on surface of CD8+ T lymphocytes were tested by the flow cytometry. Fms-like tyrosine kinase 3 ligand (Flt-3L), interleukin 17A (IL-17A), interferon γ (IFN-γ), and Interferon α2 (IFN-α2) were quantitated by Luminex assay. We use linear regression analysis to analyze their correlations to ALT, HBV DNA, HBsAg, and HBeAg.

RESULTS

The frequency of CD69+CD8+ T lymphocytes in CHB and AHB groups were increased significantly compared with IT group (4.19[3.01, 6.18]% and 4.45[2.93, 6.71]% vs. 3.02[2.17, 3.44]%; =26.207, =0.001; =28.585, =0.002), and the mean fluorescence intensity (MFI) of CD69 in AHB group was significantly higher than IT and CHB groups (27.35[24.88, 32.25] vs. 20.45[19.05, 27.75] and 23.40[16.78, 28.13]; =25.832, =0.005 and =22.056, =0.008). In IT group, HBsAg levels and HBV DNA loads were negatively correlated with CD69MFI (=-0.025, =-2.613, =0.014; =-0.021, =-2.286, =0.030), meanwhile, HBeAg was negatively related to the frequency of CD69+CD8+ T lymphocytes (=-61.306, =-2.116, =0.043). In AHB group, IFN-α2 was positively related to the frequency of CD8+ T lymphocytes (=6.798, =2.629, =0.016); however, in CHB group, IFN-α2 was negatively associated with frequency of CD8+ T lymphocytes (=-14.534, =-2.085, =0.043). In CHB group, HBeAg was positively associated with frequency of CD69+CD8+ T lymphocytes (=43.912, =2.027, =0.048). In AHB group, ALT was positively related to CD69MFI (=35.042, =2.896, =0.007), but HBsAg was negatively related to CD178MFI (=-0.137, =-3.273, =0.003).

CONCLUSIONS

The activation of CD8+ T lymphocytes was associated with the occurrence of AHB and CHB. However, due to the insufficient expression of functional molecules of CD8+ T lymphocytes and the depletion of CD8+ T lymphocytes, CHB patients were difficult to recover from HBV infection.

摘要

目的

探讨乙型肝炎病毒(HBV)感染者 CD8+T 淋巴细胞功能分子的表达、细胞因子浓度及其与乙型肝炎和 HBV 脱氧核糖核酸(DNA)、乙型肝炎表面抗原(HBsAg)、乙型肝炎 e 抗原(HBeAg)、丙氨酸氨基转移酶(ALT)发生的相关性。

方法

这是一项单中心研究。纳入 32 例急性乙型肝炎(AHB)患者、30 例免疫耐受期慢性 HBV 感染患者和 50 例慢性乙型肝炎(CHB)患者。采用流式细胞术检测 CD8+T 淋巴细胞表面的激活分子(CD69)和凋亡诱导分子(CD178)。采用 Luminex assay 定量检测 Fms 样酪氨酸激酶 3 配体(Flt-3L)、白细胞介素 17A(IL-17A)、干扰素γ(IFN-γ)和干扰素α2(IFN-α2)。采用线性回归分析来分析它们与 ALT、HBV DNA、HBsAg 和 HBeAg 的相关性。

结果

CHB 组和 AHB 组 CD69+CD8+T 淋巴细胞的频率明显高于 IT 组(4.19[3.01, 6.18]%和 4.45[2.93, 6.71]%与 3.02[2.17, 3.44]%;=26.207,=0.001;=28.585,=0.002),且 AHB 组 CD69 的平均荧光强度(MFI)明显高于 IT 组和 CHB 组(27.35[24.88, 32.25]与 20.45[19.05, 27.75]和 23.40[16.78, 28.13];=25.832,=0.005;=22.056,=0.008)。在 IT 组中,HBsAg 水平和 HBV DNA 载量与 CD69MFI 呈负相关(=-0.025,=-2.613,=0.014;=-0.021,=-2.286,=0.030),同时,HBeAg 与 CD69+CD8+T 淋巴细胞的频率呈负相关(=-61.306,=-2.116,=0.043)。在 AHB 组中,IFN-α2 与 CD8+T 淋巴细胞的频率呈正相关(=6.798,=2.629,=0.016);然而,在 CHB 组中,IFN-α2 与 CD8+T 淋巴细胞的频率呈负相关(=-14.534,=-2.085,=0.043)。在 CHB 组中,HBeAg 与 CD69+CD8+T 淋巴细胞的频率呈正相关(=43.912,=2.027,=0.048)。在 AHB 组中,ALT 与 CD69MFI 呈正相关(=35.042,=2.896,=0.007),但 HBsAg 与 CD178MFI 呈负相关(=-0.137,=-3.273,=0.003)。

结论

CD8+T 淋巴细胞的激活与 AHB 和 CHB 的发生有关。然而,由于 CD8+T 淋巴细胞功能分子表达不足和 CD8+T 淋巴细胞耗竭,CHB 患者难以从 HBV 感染中恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897c/9637985/3a4ff2e24ea8/fimmu-13-1036612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897c/9637985/3a4ff2e24ea8/fimmu-13-1036612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897c/9637985/3a4ff2e24ea8/fimmu-13-1036612-g001.jpg

相似文献

1
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.细胞因子谱和 CD8+T 细胞在急性和慢性乙型肝炎中的发生。
Front Immunol. 2022 Oct 24;13:1036612. doi: 10.3389/fimmu.2022.1036612. eCollection 2022.
2
Association of cytokines with hepatitis B virus and its antigen.细胞因子与乙型肝炎病毒及其抗原的关联。
J Med Virol. 2020 Dec;92(12):3426-3435. doi: 10.1002/jmv.26301. Epub 2020 Aug 21.
3
Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.慢性乙型肝炎中细胞因子与丙氨酸氨基转移酶、乙型肝炎病毒表面抗原和乙型肝炎 envelope 抗原水平的关系。
Chin Med J (Engl). 2018 Aug 5;131(15):1813-1818. doi: 10.4103/0366-6999.237394.
4
Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection.浆细胞样树突状细胞在急性或慢性乙型肝炎病毒感染患者中的功能和细胞因子网络特征。
Chin Med J (Engl). 2018 Jan 5;131(1):43-49. doi: 10.4103/0366-6999.221275.
5
Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.未经治疗的慢性乙型肝炎患者 T 细胞产生的细胞因子与临床病毒学特征之间的相关性。
BMC Infect Dis. 2019 Mar 4;19(1):216. doi: 10.1186/s12879-019-3853-2.
6
Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.研究慢性乙型肝炎病毒感染者体内乙型肝炎病毒自发清除过程中 CD8+记忆 T 细胞亚群分布及 IFN-γ水平的变化。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4675-4679.
7
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients.聚乙二醇干扰素α-2a 治疗 HBeAg 阳性慢性乙型肝炎患者时与 HBsAg 消失相关的细胞因子谱和病毒学标志物的动态变化。
Front Immunol. 2022 May 4;13:892031. doi: 10.3389/fimmu.2022.892031. eCollection 2022.
8
Transforming growth factor β as a possible independent factor in chronic hepatitis B.转化生长因子 β 作为慢性乙型肝炎的一个可能的独立因素。
Arch Virol. 2021 Jul;166(7):1853-1858. doi: 10.1007/s00705-021-05062-6. Epub 2021 Apr 19.
9
[The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection].[乙肝病毒感染患者T细胞对乙肝病毒特异性抗原蛋白的反应特征]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Aug;26(4):253-5.
10
Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.调节性 T 细胞和 Th17 细胞平衡在急性和慢性乙型肝炎病毒感染发展中的变化。
BMC Gastroenterol. 2012 May 1;12:43. doi: 10.1186/1471-230X-12-43.

引用本文的文献

1
Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency-Clinical and Immunotransplant Implications with a Review of the Literature.B细胞在乙肝病毒诱导的肿瘤发生中超越抗体的作用:常见可变免疫缺陷中的暴发性癌症——临床及免疫移植意义并文献综述
Diseases. 2024 Apr 23;12(5):80. doi: 10.3390/diseases12050080.
2
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction.MHC Ⅱ类转录激活因子在乙型肝炎病毒复制和病毒拮抗中的新作用
Clin Mol Hepatol. 2024 Jul;30(3):539-560. doi: 10.3350/cmh.2024.0060. Epub 2024 May 14.

本文引用的文献

1
An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients.优化的干扰素间歇治疗模式有助于提高慢性乙型肝炎患者的乙肝表面抗原消失率。
Front Microbiol. 2022 Aug 30;13:960589. doi: 10.3389/fmicb.2022.960589. eCollection 2022.
2
HBV-Specific CD8+ T-Cell Tolerance in the Liver.HBV 特异性 CD8+ T 细胞在肝脏中的耐受。
Front Immunol. 2021 Aug 6;12:721975. doi: 10.3389/fimmu.2021.721975. eCollection 2021.
3
WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBV: A US Perspective.
世界卫生组织乙型肝炎病毒感染者预防、护理和治疗指南:美国视角。
Clin Liver Dis. 2019 Aug;23(3):417-432. doi: 10.1016/j.cld.2019.04.008.
4
Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.慢性乙型肝炎的预防、诊断及治疗最新进展:美国肝病研究学会2018年乙型肝炎指南
Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul.
5
Hepatitis B virus-specific effector CD8 T cells are an important determinant of disease prognosis: A meta-analysis.乙型肝炎病毒特异性效应 CD8 T 细胞是疾病预后的一个重要决定因素:一项荟萃分析。
Vaccine. 2019 Apr 24;37(18):2439-2446. doi: 10.1016/j.vaccine.2019.03.058. Epub 2019 Mar 29.
6
Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.慢性乙型肝炎中细胞因子与丙氨酸氨基转移酶、乙型肝炎病毒表面抗原和乙型肝炎 envelope 抗原水平的关系。
Chin Med J (Engl). 2018 Aug 5;131(15):1813-1818. doi: 10.4103/0366-6999.237394.
7
The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment.聚乙二醇化干扰素α-2a治疗HBeAg阳性慢性乙型肝炎患者时,基线HBsAg水平及早期应答对HBsAg消失的预测价值
Biomed Environ Sci. 2017 Mar;30(3):177-184. doi: 10.3967/bes2017.025.
8
Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment.聚乙二醇化干扰素α-2a治疗期间实现乙肝表面抗原消失的慢性乙型肝炎患者的乙肝表面抗原水平动力学
Chin Med J (Engl). 2017 Mar 5;130(5):559-565. doi: 10.4103/0366-6999.200554.
9
Impact of HBeAg on the maturation and function of dendritic cells.HBeAg 对树突状细胞成熟和功能的影响。
Int J Infect Dis. 2016 May;46:42-8. doi: 10.1016/j.ijid.2016.03.024. Epub 2016 Mar 29.
10
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.欧洲肝脏研究学会-阿莱赫临床实践指南:用于评估肝脏疾病严重程度和预后的非侵入性检查
J Hepatol. 2015 Jul;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006. Epub 2015 Apr 21.